MetaVia (MTVA) Research & Development (2015 - 2026)
MetaVia's Research & Development was $3.48 million in Q2 2026, up 49.9% from $2.32 million a year earlier.
Powered by 
Analysis
MetaVia (MTVA) Research & Development (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, MetaVia's Research & Development was $7.95 million through Jun 30, 2026, down 39.9% year-over-year; for FY2025, it was $6.8 million, down 68.4% from FY2024.
- In earlier years, Research & Development was $21.55 million in FY2024 (+135.3%) and $9.16 million in FY2023.
- The Q2 2026 figure marks the highest quarterly Research & Development since Q4 2024.
- Compared with a year earlier, Research & Development was higher in three of the last seven quarters, with an average decline of 17.6%.
- The best year-over-year quarter for Research & Development over five years was Q3 2024 (growth of 97.1%); the worst was Q4 2025 (a decline of 94.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | MetaVia | 10.98 Mn | -43.83 Mn | - | 3.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.48 Mn |
| Dec 31, 2025 | 241,000.00 |
| Sep 30, 2025 | 1.91 Mn |
| Jun 30, 2025 | 2.32 Mn |
| Mar 31, 2025 | 2.33 Mn |
| Dec 31, 2024 | 4.06 Mn |
| Sep 30, 2024 | 4.52 Mn |
| Jun 30, 2024 | 8.07 Mn |
| Mar 31, 2024 | 4.90 Mn |
| Dec 31, 2023 | 3.87 Mn |
| Sep 30, 2023 | 2.29 Mn |
| Sep 30, 2019 | 1.07 Mn |
| Jun 30, 2019 | 1.23 Mn |
| Mar 31, 2019 | 1.39 Mn |
| Dec 31, 2018 | 1.83 Mn |
| Sep 30, 2018 | 3.54 Mn |
| Jun 30, 2018 | 3.96 Mn |
| Mar 31, 2018 | 4.98 Mn |
| Dec 31, 2017 | 5.08 Mn |
| Sep 30, 2017 | 6.49 Mn |
API Access
MetaVia Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=MTVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "MTVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=MTVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();